XML 20 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Tables)
12 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
(in millions)
2014
 
2013
 
2012
Pharmaceutical (1)
$
80,110

 
$
91,097

 
$
97,925

Medical
10,962

 
10,060

 
9,642

Total segment revenue
91,072

 
101,157

 
107,567

Corporate (2)
12

 
(64
)
 
(15
)
Total revenue
$
91,084

 
$
101,093

 
$
107,552


(1)
Our pharmaceutical distribution contract with Walgreens expired on August 31, 2013. Our pharmaceutical distribution contract with Express Scripts, Inc. expired on September 30, 2012.
(2)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
(in millions)
2014
 
2013
 
2012
Pharmaceutical
$
1,745

 
$
1,734

 
$
1,558

Medical
444

 
372

 
332

Total segment profit
2,189

 
2,106

 
1,890

Corporate
(304
)
 
(1,110
)
 
(98
)
Total operating earnings
$
1,885

 
$
996

 
$
1,792

Assets by Reportable Segments
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)
2014
 
2013
 
2012
Pharmaceutical
$
15,361

 
$
16,258

 
$
16,642

Medical
6,768

 
6,521

 
4,399

Corporate
3,904

 
3,040

 
3,219

Total assets
$
26,033

 
$
25,819

 
$
24,260

Schedule of Revenue and Property and Equipment, net by Geographical Areas
The following tables present revenue and property and equipment, net by geographic area:
(in millions)
2014
 
2013
 
2012
United States
$
87,449

 
$
97,994

 
$
105,205

International
3,635

 
3,099

 
2,347

Total revenue
$
91,084

 
$
101,093

 
$
107,552

(in millions)
2014
 
2013
 
2012
United States
$
1,301

 
$
1,355

 
$
1,425

International
158

 
134

 
126

Property and equipment, net
$
1,459

 
$
1,489

 
$
1,551

Depreciation and Amortization by Segment
 
Segment Reporting, Other Significant Reconciling Item [Line Items]  
Schedule of Other Significant Items by Segments
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and at Corporate:
(in millions)
2014
 
2013
 
2012
Pharmaceutical
$
128

 
$
125

 
$
114

Medical
130

 
137

 
119

Corporate
201

 
135

 
92

Total depreciation and amortization
$
459

 
$
397

 
$
325

Additions to Property and Equipment by Segment
 
Segment Reporting, Other Significant Reconciling Item [Line Items]  
Schedule of Other Significant Items by Segments
(in millions)
2014
 
2013
 
2012
Pharmaceutical
$
72

 
$
46

 
$
44

Medical
72

 
48

 
100

Corporate
105

 
101

 
116

Total additions to property and equipment
$
249

 
$
195

 
$
260